Need Help?
Contact Us

ENERGEN™

Implantable Cardioverter Defibrillator (ICD)

The ENERGEN ICD, with the 4‐SITE™ DF4 connector system, is designed to streamline the implant procedure and make the thinnest, long‐lasting high‐energy devices in the world even smaller.

Key Resources

Directions for Use Indications, Safety and Warnings

Explore

 

Product Details

The ENERGEN ICD, with the 4‐SITE™ DF4 connector system, was designed to streamline the implant procedure and make the thinnest, long‐lasting high‐energy devices in the world even smaller.

85% of patients would prefer a device that is thinner and wider, rather than thick and narrow1

Designed to further enhance patient comfort, when used in conjunction with the ENERGEN ICD device systems, the RELIANCE™ lead with 4‐SITE makes the thinnest high‐energy device system in the world even smaller. The ENERGEN VR ICD with the 4‐SITE connector system is the world’s first 30.5 cc high‐energy ICD.

ENERGEN ICDs are the smallest high-energy devices on the market without sacrificing on device longevity, which is supported by our industry‐leading warranty covering device replacements for up to 10 years.

A Streamlined Implant

The proprietary EZ-4 connector tool is the only DF4 accessory designed to streamline the implant procedure by helping physicians perform the following four functions:

Protecting the lead terminal during the implant procedure

Providing a safe and secure connection between pacing system analyzer (PSA) patient cables and the lead terminal

Guiding the stylet into the lead through the funnel

Rotating the terminal pin clockwise or counterclockwise to extend or retract the helix for leads with an extendable/retractable helix

Ultimately, the RELIANCE lead with 4‐SITE eliminates the potential to reverse positive and negative DF-1 connections and reduces lead pocket bulk by 30% via the elimination of the yoke and combining three terminals into that single DF4 connection.

Reimbursement

Rhythm Management reimbursement resources


References

1 High Voltage Patient Survey, January 2011. Double-blind online survey administered by 3rd party vendor; conducted among 189 high voltage device patients. Data on file.

Follow Boston Scientific Cardiology: Twitter LinkedIn YouTube Google+
Top